Australian vaccine researchers have launched clinical trials investigating whether a 3-in-1 jab produced by Moderna could target Covid, Flu and RSV.
A report from 7News Australia follows a University of the Sunshine Coast clinical trial developing a jab that would supposedly protect against all three viruses.
“If the vaccine works, the trial could be extended to younger people,” says reporter Ned Balme, noting the all-in-one jab could help alleviate stress on the overburdened health care system and ease stress for vaccine-fatigued recipients.
News of Moderna’s latest jab comes as the company is also researching a new mRNA shot meant to treat patients who suffered heart failure, ironically a side effect that’s been linked to both Moderna and Pfizer experimental Covid jabs.
Moderna CEO Stéphane Bancel Announces New mRNA Shot to Treat Heart Failure Patients
“We are now in a super exciting program where we inject mRNA in people’s heart after a heart attack to grow back new blood vessels and re-vascularize the heart”https://t.co/kI3afoLU89 pic.twitter.com/zNw4rQN0Lv
— Chief Nerd (@TheChiefNerd) January 11, 2023
Reports of heart inflammation cases grew so prevalent during the initial vaccine rollout that even the CDC was forced to address the issue claiming the side effects were rare and mostly affected young adult males.
Other medical doctors and researchers have disputed the rarity of such heart inflammation cases and contend the risk correlates with the amount of jabs and boosters injected.
Reports also surfaced Wednesday Moderna is looking at raising the price of its mRNA Covid jab from $26 to $110-$140 per dose, an incredible increase of 400%.